4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, J; Jia, JJ; Kwon, Y; Wang, SD; Zeng, XS | 1 |
1 other study(ies) available for 4-phenyl-1,2,3,6-tetrahydropyridine and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
The role of thioredoxin-1 in suppression of endoplasmic reticulum stress in Parkinson disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Caspase 12; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Endoribonucleases; Gene Expression Regulation; Heat-Shock Proteins; MAP Kinase Kinase 4; Mice; Mice, Transgenic; MPTP Poisoning; PC12 Cells; Protein Serine-Threonine Kinases; Rats; Signal Transduction; Thioredoxins; TNF Receptor-Associated Factor 2; Transcription Factor CHOP | 2014 |